000 01528 a2200445 4500
005 20250513220455.0
264 0 _c20001026
008 200010s 0 0 eng d
022 _a0160-564X
024 7 _a10.1046/j.1525-1594.2000.06615.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTayama, E
245 0 0 _aBiocompatibility of heparin-coated extracorporeal bypass circuits: new heparin bonded bioline system.
_h[electronic resource]
260 _bArtificial organs
_cAug 2000
300 _a618-23 p.
_bdigital
500 _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
650 0 4 _aAged
650 0 4 _aAnalysis of Variance
650 0 4 _aAnticoagulants
_xadministration & dosage
650 0 4 _aCardiopulmonary Bypass
_xinstrumentation
650 0 4 _aCoated Materials, Biocompatible
650 0 4 _aComplement C3a
_xmetabolism
650 0 4 _aFemale
650 0 4 _aHeparin
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aInterleukin-6
_xmetabolism
650 0 4 _aInterleukin-8
_xmetabolism
650 0 4 _aLeukocyte Elastase
_xmetabolism
650 0 4 _aMale
650 0 4 _aMaterials Testing
700 1 _aHayashida, N
700 1 _aAkasu, K
700 1 _aKosuga, T
700 1 _aFukunaga, S
700 1 _aAkashi, H
700 1 _aKawara, T
700 1 _aAoyagi, S
773 0 _tArtificial organs
_gvol. 24
_gno. 8
_gp. 618-23
856 4 0 _uhttps://doi.org/10.1046/j.1525-1594.2000.06615.x
_zAvailable from publisher's website
999 _c10918690
_d10918690